PRO: Cardiac Catheterization Is the Optimal Strategy for Cardiovascular Risk Stratification in This Patient
Brett Sadowski, Tilak Baba, Amol S. Rangnekar – 31 January 2021
COVID‐19 and Liver Cirrhosis: Focus on the Nonclassical Renin‐Angiotensin System and Implications for Therapy
Giovanni Sansoè, Manuela Aragno, Florence Wong – 31 January 2021
Insights Into Metabolic Mechanisms and Their Application in the Treatment of NASH
Phillip J. White, Manal F. Abdelmalek – 31 January 2021
Nonalcoholic Fatty Liver Disease and Cardiovascular Disease
Eric M. Przybyszewski, Giovanni Targher, Michael Roden, Kathleen E. Corey – 31 January 2021
Seeking Editor for Hepatology Communications
31 January 2021
Impact of COVID‐19 Response on Hepatitis Prevention Care and Treatment: Results From Global Survey of Providers and Program Managers
Jessica Laury, Lindsey Hiebert, John W. Ward – 31 January 2021
The Influence of the Microbiome on NAFLD and NASH
Somaya A.M. Albhaisi, Jasmohan S. Bajaj – 31 January 2021
Introduction to the Nonalcoholic Fatty Liver Disease Special Issue
Cynthia A. Moylan – 31 January 2021
The Role of Life Style Modifications in Comprehensive Non‐Alcoholic Fatty Liver Disease Treatment
Kathleen Viveiros – 31 January 2021
Nonalcoholic Fatty Liver Disease and Recent Guideline Updates
Yumi Ando, Janice H. Jou – 31 January 2021